I62M (p.Ile62Met) variant of IL17F (Interleukin-17F)
I62M (p.Ile62Met) in IL17F (Interleukin-17F) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes variant effect predictions and structural context.
I62M (p.Ile62Met) variant details
- p.Ile62Met
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- MetaLR 0.03
- MetaSVM -1.03
- SIFT 0.48
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available